PMV is a Private Equity investor with a Venture Capital franchise in Life Sciences. Through this activity, initiated in 2006, we support highly innovative companies with the potential to generate financial return both for our funds and the region of Flanders. Being a very active investor, PMV helps building businesses by investing in both early- and growth stage companies in all areas of biotech and healthcare, ie therapeutics, diagnostics, medical devices, digital healthcare and next generation technologies. Our current portfolio in Life Sciences includes leading biotech companies, such as Biocartis, eTheRNA, Complix, Confo Therapeutics, Feops, Argen-x and Celyad.